anonymous
Guest
anonymous
Guest
Anyone else looking to leave after this reorg?
I think you will see a definite rise in exits. Add in the poor results in the nurtec head to head study, those left in spec don't have much to keep them engaged.
dumbassSorry not sorry
Love,
Pfizer
Pfizer…
Your company sucks… and you can say whatever but your drug is solely an abortive. It’s a wannabe preventive but not used much at all. Cost sucks and side effects too. Good luck with the wannabe one stop wonder haha
If you’re curious, whether or not you can earn points on your corporate spend, this is probably not the right place for you.
I think you will see a definite rise in exits. Add in the poor results in the nurtec head to head study, those left in spec don't have much to keep them engaged.
It is being run by the biggest set of dip sh!ts that are diabetes rejects. Run its a nightmare.I'm seeing roles posted for Alzheimers Consultants - is this also under the neuroscience division? Any feedback on what the culture is like for this team? Is it specialty? Any idea if the corporate card is Amex and if they would allow you to link your membership to the card? (not a deal breaker but just curious)
Anyone else looking to leave after this reorg?
Ooo I bet you're wonderin' how I knewWhat's happening with the re-org? I heard that Emgality sales force is going to be reduced and some shifted over to AD?!?